The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial

Background: Right heart abnormalities and pulmonary hypertension (PH) may be secondary to chronic lung disease. Chronic lung disease is common in children with HIV. In the BREATHE trial (Trial registration: NCT02426112), azithromycin (AZM) reduced the risk of acute respiratory exacerbations in child...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Edith D. Majonga, Gugulethu Newton Mapurisa, Andrea M. Rehman, Grace McHugh, Tsitsi Bandason, Hilda Mujuru, Carmen Gonzalez-Martinez, Jon O. Odland, Neil Kennedy, Rashida A. Ferrand
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
HIV
Accès en ligne:https://doaj.org/article/b795618d2b244eca8e24f8b61cf344f4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!